Page last updated: 2024-10-14

fumiquinazoline c

Description

fumiquinazoline C: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

fumiquinazoline C : A fumiquinazoline obtained by oxidative spirocyclisation of fumiquinazoline A. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11339719
CHEBI ID64551
SCHEMBL ID12931224
MeSH IDM0424394

Synonyms (9)

Synonym
fumiquinazoline c
(1s,2's,3s,5r,9a's)-1,2'-dimethyl-1',9a'-dihydro-4h-spiro[1,5-(epiminomethano)[1,4]oxazepino[3,4-b]quinazoline-3,9'-imidazo[1,2-a]indole]-3',7,13(1h,2'h,5h)-trione
CHEBI:64551
SCHEMBL12931224
(1r,2's,3'as,12s,14s)-2',12-dimethylspiro[13-oxa-2,10,17-triazatetracyclo[10.3.2.02,11.04,9]heptadeca-4,6,8,10-tetraene-14,4'-3,3a-dihydro-2h-imidazo[1,2-a]indole]-1',3,16-trione
DTXSID80893275
140924-01-2
Q27133343
C22148
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (5)

ClassDescription
fumiquinazolineA group of indole alkaloids biosynthesised using L-tryptophan, L-alanine and anthranilic acid building blocks.
imidazoindoleAny organic heterotricyclic compound that consists of an imidazole ring ortho-fused to an indole.
oxaspiro compoundA spiro compound in which at least one of the cyclic components is an oxygen heterocyle.
azaspiro compoundAn azaspiro compound is a spiro compound in which at least one of the cyclic components is a nitrogen heterocyle.
organic heteroheptacyclic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
fumiquinazoline D biosynthesis515

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]